We are live on ! Find out more
BIAF icon

bioAffinity Technologies
BIAF

15 hedge funds and large institutions have $499K invested in bioAffinity Technologies in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,337% more capital inflows, than outflows

Capital inflows: $98.4K | Capital outflows: $6.85K

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

25% more funds holding

Funds holding: 12 → 15 (+3)

0.03% less ownership

Funds ownership: 3.48% → 3.45% (-0.03%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Sheaff Brock Investment Advisors
Sheaff Brock Investment Advisors
Indiana
+$35.6K
2
Two Sigma Securities
Two Sigma Securities
New York
+$19.3K
3
Citadel Advisors
Citadel Advisors
Florida
+$17.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.3K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$5.43K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.04K
2
XTX Topco
XTX Topco
Cayman Islands
-$604
3
Clear Street
Clear Street
New York
-$208

BIAF Hedge Fund Activity: Q4 2024 in Review

15 of the 7,624 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q4 2024, worth a combined $499K — down 49% from $975K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIAF positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Sheaff Brock Investment Advisors, adding an estimated $35.6K. The largest seller was Morgan Stanley, cutting an estimated $6.04K.

  • 15 institutional investors held bioAffinity Technologies (BIAF) as of Q4 2024, up from 12 in Q3 2024.
  • Funds reported $499K of bioAffinity Technologies stock for Q4 2024, down 49% quarter-over-quarter.
  • 3 funds opened new bioAffinity Technologies positions in Q4 2024 and 0 closed out, a net change of +3 holders.
  • The largest bioAffinity Technologies buyer in Q4 2024 was Sheaff Brock Investment Advisors, an estimated $35.6K added.
  • The largest bioAffinity Technologies seller in Q4 2024 was Morgan Stanley, an estimated $6.04K sold.

Based on aggregated 13F filings for Q4 2024.